A conversation with Dr. Scott Struthers, Founder, and CEO of Crinetics Pharmaceutical.
These are exciting times in the world of endocrine drug discovery and development, particularly for Acromegaly and Cushing’s patients. I today’s podcast we talk to Dr. Struthers about the prospects for new drugs, his experiences as an endocrine scientist and his expectations for success.
In addition, they are presently conducting two trials for their
#ACROBAT Phase 2 trials in #Acromegaly for their small-molecule oral somatostatin agonist, CRN00808! click here for details and a direct link to the studies.
© 2017 – 2019, Pituitary World News. All rights reserved.